Mapping/Ablation

In this preview of the Women in EP Luncheon at Heart Rhythm 2026, Dr Reynbakh shares insights on what makes this a meaningful and practical experience for attendees at every career stage.

Kenneth Bilchick, MD, MS, discusses the vision behind the newly established HRS Research Network and the critical need for stronger collaboration, mentorship, and infrastructure in heart rhythm research.

Eduardo Saad, MD, PhD and Christina Miyake, MD, MS, Chair and Vice-Chair for the Global Relations Committee, share key insights from the Global Summit at Heart Rhythm 2026: Sports, Exercise, and Medicine—The Athlete’s Heart and Beyond.

Arash Aryana, MD, PhD, and Vijendra Swarup, MD, examine the evidence base, operational and regulatory requirements, ownership considerations, and unresolved structural needs shaping the future of EP-capable ASCs.

Dr Sadhu describes the procedural workflow, patient selection criteria, and clinical rationale for a combined approach integrating PFA, 3D electroanatomic mapping, and 4D ICE with LAAO for the treatment of AF in older patients.

Sri Sundaram, MD, shares insights from a high-volume program performing more than 3000 EP procedures and approximately 1000 ablations annually, nearly all without fluoroscopy.

To evaluate whether a mapping system is necessary for PFA, a group in Basel, Switzerland, studied the role of 3D electroanatomic mapping on procedural characteristics and outcomes in patients undergoing PFA for AF.

In this interview, Dr Birgersdotter-Green shares her perspective on why rapid-format mentoring can be especially impactful.

Amanda Randles, PhD, explores how cardiovascular “digital twins” could move arrhythmia care beyond reactive monitoring toward proactive, personalized management.

Atman P Shah, MD, FSCAI, FPICS, discusses current challenges in left atrial appendage closure (LAA) and shares insights into the early development of an investigational device designed to provide a more personalized approach to LAA closure.